Promedica, Inc. (www.promedicainc.com), a leading market research firm serving pharmaceutical and biotechnology companies, has been sold to Cello Group plc (www.cellogroup.com), the healthcare and consumer strategic marketing group. Promedica will form part of Cello Health.

Stephen Highley, Chairman of Cello Health, commented, “We’re delighted to warmly welcome Promedica into Cello Health. This experienced and talented team will now open up capacity on the West Coast of America where we are seeing significant activity from both pharmaceutical and biotechnology clients.”

JEGI CLARITY represented Promedica in this transaction.